Ureteral Stent
- UID
- IMP/MD/2018/000016_e0e7f84fa336a7ce49c5b4279b636370_497cb0b1ff9867af19e9d04453d8861c
- Device class
- Class B
- Brand name
- BARD Nicore Nitinol Guidewire
- License holder
- Bard India Healthcare Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- Indicated to relieve obstruction in a variety of benign, malignant and post-traumatic conditions in the ureter. These conditions include stones and / or stone fragments, or other Ureteral obstructions such as those associated with Ureteral stricture, malignancy of abdominal organs, retroperitoneal fibrosis or Ureteral trauma, or in association with Extracorporeal Shock Wave Lithotripsy (BARD Nicore Nitinol Guidewire). The sent may be placed using endoscopic surgical techniques or percutaneouly using standard radiographic technique. It is recommended that the indwelling time not exceed 365 days. The stent is not intended as a permanent indwelling device
Ureteral Stent is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000016_e0e7f84fa336a7ce49c5b4279b636370_497cb0b1ff9867af19e9d04453d8861c. This device is marketed under the brand name BARD Nicore Nitinol Guidewire. The license holder is Bard India Healthcare Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.